Anastasiya Muntyanu Selected Research

Arthritis (Polyarthritis)

12/2016

Differential gene and protein expression of chemokines and cytokines in synovial fluid of patients with arthritis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Anastasiya Muntyanu Research Topics

Disease

3	Systemic Scleroderma (Systemic Sclerosis) 05/2023 - 01/2022
3	Neoplasms (Cancer) 01/2021 - 01/2020
2	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2023 - 12/2016
2	Bullous Pemphigoid (Pemphigoid) 07/2022 - 01/2022
2	Chronic Urticaria 01/2022 - 03/2020
2	Atopic Dermatitis (Atopic Eczema) 01/2022 - 05/2021
2	Dermatitis 01/2022 - 05/2021
2	Pemphigus (Pemphigus Vulgaris) 01/2021 - 09/2020
2	Lymphoma (Lymphomas) 01/2021 - 09/2020
1	Latent Tuberculosis 01/2023
1	Dermatomyositis (Dermatopolymyositis) 12/2022
1	Cutaneous Lupus Erythematosus 12/2022
1	Carcinogenesis 12/2022
1	Inflammation (Inflammations) 01/2022
1	Disease Susceptibility (Diathesis) 01/2022
1	Skin Diseases (Skin Disease) 01/2022
1	Neurodermatitis (Lichen Simplex Chronicus) 01/2022
1	Eosinophilia 01/2022
1	Skin Neoplasms (Skin Cancer) 01/2022
1	Conjunctivitis 05/2021
1	Eczema 05/2021
1	Pruritus (Itching) 05/2021
1	Stevens-Johnson Syndrome (Lyell's Syndrome) 01/2021
1	Heart Diseases (Heart Disease) 01/2020
1	Gout 12/2016
1	Arthritis (Polyarthritis) 12/2016

Drug/Important Bio-Agent (IBA)

3	Monoclonal AntibodiesIBA 01/2022 - 01/2021
2	Omalizumab (Xolair)FDA Link 07/2022 - 03/2020
2	dupilumabIBA 01/2022 - 05/2021
2	CytokinesIBA 01/2022 - 12/2016
2	Rituximab (Mabthera)FDA Link 01/2021 - 09/2020
1	SolventsIBA 05/2023
1	Rifampin (Rifampicin)FDA LinkGeneric 01/2023
1	RNA (Ribonucleic Acid)IBA 12/2022
1	CollagenIBA 12/2022
1	Long Noncoding RNAIBA 12/2022
1	InterferonsIBA 12/2022
1	Silicon Dioxide (Silica)FDA LinkGeneric 01/2022
1	Immunoglobulin E (IgE)IBA 01/2022
1	InterleukinsIBA 05/2021
1	lebrikizumabIBA 05/2021
1	Immunoglobulin A (IgA)IBA 05/2021
1	Interleukin-13IBA 05/2021
1	Immune Checkpoint InhibitorsIBA 01/2021
1	ligelizumabIBA 03/2020
1	Acute-Phase Proteins (Acute-Phase Protein)IBA 01/2020
1	ChemokinesIBA 12/2016
1	Interleukin-17 (Interleukin 17)IBA 12/2016
1	Chemokine CXCL10IBA 12/2016
1	Biomarkers (Surrogate Marker)IBA 12/2016
1	Proteins (Proteins, Gene)FDA Link 12/2016

Therapy/Procedure

2	Therapeutics 01/2022 - 01/2021
1	Biological Therapy 05/2021
1	Immunotherapy 01/2021
1	Ambulatory Care (Outpatient Care) 01/2021